One Case of Acute Hepatic Injury Caused by Ioversol Injection

doi:10.19803/j.1672-8629.20240464

Abstract

Abstract: Objective To analyze one case of hepatic injury caused by ioversol injection in order to provide a reference for clinical use. Methods The clinical data of a 70-year-old male patient who experienced persistent elevation of liver enzymes after receiving ioversol injection was analyzed. The correlations between hepatic injury and ioversol injection were studied, and a literature review was conducted to identify cases of contrast agent-induced hepatic injury and potential causes. Results Based on correlation assessment, the severe liver injury in this patient was believed to have been caused by administration of ioversol injection. The patient’s liver function gradually improved after hepatoprotective treatment. Conclusion Ioversol injection may cause adverse reactions that lead to hepatic dysfunction. Clinicians should be aware of the risk of adverse drug reactions associated with ioversol injection and enhance monitoring.

Key words: Ioversol, Injection, Contrast, Acute Hepatic Injury, Liver Enzymes, Adverse Drug Reaction

CLC Number:

YU Li, TAN Xiying. One Case of Acute Hepatic Injury Caused by Ioversol Injection[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 343-345.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20240464

https://zgywjj.magtechjournal.com/EN/Y2025/V22/I3/343

References

[1] ZHOU XD, FENG GW, LI D, et al.Signal Mining and Risk Factor Analysis of Iodinated Contrast Media Adverse Reactions Based on the FAERS Database[J].Journal of Clinical Radiology(临床放射学杂志),2023, 42(4): 683-691.
[2] BÖHM I, MORELLI J, NAIRZ K, et al. Myths and Misconceptions Concerning Contrast Media-Induced Anaphylaxis: a Narrative Review[J].Postgrad Med, 2017, 129(2): 259-266.
[3] ZHANG D, LI L, XU HW, et al.Analysis of 110 Cases of Adverse Drug Reactions to Iodixanol[J].Chinese Journal of Pharmacovigilance(中国药物警戒),2022, 19(1): 83-86.
[4] QIU HY, WANG LR, LI JJ, et al.Acute Adverse Reactions and Influencing Factors of Non-Ionic Iodine Contrast in 332683 Patients Undergoing Contrast-Enhanced CT Scanning[J].Journal of Army Medical University(陆军军医大学学报),2023, 45(3): 257-264.
[5] JIA D, ZHAO X, ZHAO HY, et al.One Case of Contrast Agent-Induced Hepatorenal Dysfunction Resulting in Death[J].Journal of Practical Medicine(实用医学杂志),2012, 28(20): 3501.
[6] YANG Q, LIU S, MI JL, et al.Pharmaceutical Practice in a Case of Iopromide-Induced Renal Injury Leading to Severe Hepatic Injury from Enoxaparin[J].Chinese Journal of Pharmacoepidemiology(药物流行病学杂志),2023, 32(7): 836-840.
[7] DA SILVA PSL, KUBO EY, FONSECA MCM.Severe Liver and Renal Injuries Following Cerebral Angiography: Late Life-Threatening Complications of Non-Ionic Contrast Medium Admin-istration[J].Childs Nerv Syst, 2016, 32: 733-737.
[8] MORITA Y, KAWAMOTO C, SATO K, et al.Severe Liver Injury with Hematological Disorders Following the Injection of Non-Ionic Contrast Medium. A Case Report[J].Acta Radiol, 2001, 42(3): 342-344.
[9] BOLADO CF, CAPDEVILA BF, ZOZAYA UJM, et al.Hepatotoxicity Caused by Iopromide[J].Rev Esp Enferm Dig, 2008, 100(6): 377-378.
[10] MA SW, LIU CH, LIU XY, et al.Chinese Guideline for Diagnosis and Management of Drug-Induced Liver Injury(2023 Version)[J].Chinese Journal of Gastroenterology(胃肠病学),2023, 28(7): 397-431.

[1]	LONG Minjuan, ZHAO Xu, GUO Longxin, CAI Yuhan, LIN Li, ZHU Shengkai, LIU Wenlong, SONG Haibo, XIAO Xiaohe. Big Data Analysis of Liver Adverse Reactions Monitoring of Chinese and Western Medicines Based on Age Correction and Risk Warning for Dermatologic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 271-275.
[2]	LIAO Mengfan, ZHONG Liling, XU Yan, LIU Ying, ZHANG Yexiang, CHEN Qingsong, LIU Xudong. Adverse Reactions to Antihypertensive and Hypoglycaemic Drugs Based on Spontaneous Presentation Systems [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 286-291.
[3]	LIU Chenpei, DU Yupeng, LIN Yan. One Case of Anemia Caused by Finerenone Tablets [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 334-336.
[4]	HU Kun, HUANG Weiguo, LEI Lili, PANG Xiaocong, ZHOU Ying, CUI Yimin. One Case of Bone Marrow Suppression Caused by Azathioprine Tablets in a Patient with TPMT Heterozygous Mutation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 337-340.
[5]	FU Xiaoyan, GOU Yu, LUO Xianhai, HU Qiaozhi. One Case of Anaphylactic Shock Caused by Multiple Oral Cephalexin Capsules Combined with Oolong Tea [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 341-342.
[6]	MIN Qiong, LI Peng, DAI Xiaoyan, FAN Chunling, YOU Haisheng. One Case of Neurotoxicity Caused by Fluorouracil Injection in a Patient with Metastatic Colorectal Cancer [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 346-348.
[7]	ZHU Lan, SHAO Bo, ZHU Yan, DAI Jie, ZHONG Shiqi. Current Progress and Considerations in Updating the Safety Information in Labels of Chinese Traditional Patent Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 188-192.
[8]	LIU Biqing, ZHANG Xiaotong, WANG Ke, XING Xiaoxuan, WANG Zhizhou, ZHUANG Wei, ZHANG Qingxia, ZHANG Lan, LI Xiaoling, DONG Xianzhe. Adverse Drug Reaction in 385 Elderly Inpatients with Bacterial Pneumonia under Polypharmacy [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 206-210.
[9]	LI Xiaobo, ZHOU Guojian, HUANG Yuling, LI Haiqiao, CHEN Tingting. One Case of Red Man Syndrome Caused by Locally-Used Low-Dose Vancomycin [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 217-220.
[10]	WANG Songlan, SUN Ying, CHEN Aiqun, JI Liwei. One Case of Acute Kidney Injury Induced by Evolocumab Injection in a Patient with Chronic Kidney Disease after Renal Transplantation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 221-223.
[11]	HU Yaping, ZHANG Aiwu. One Case of Acute Drug-Induced Liver Injury Caused by Tingli Jiangxuezhi Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 224-226.
[12]	KOU Jiejian, WANG Yangai. One Case of Thrombocytopenia and Leukopenia Induced by Teicolanin and Rebabapide [J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 227-230.
[13]	NIE Xiaolu, SUN Feng, YAN Aixia, PENG Xiaoxia, ZHAN Siyan. Methodology for Constructing Benchmark Database of Adverse Drug Reactions Based on Multi-Source Information [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 10-15.
[14]	NIE Xiaolu, ZHAO Houyu, HUO Donghui, YAN Aixia, SUN Feng, PENG Xiaoxia, NI Xin, ZHAN Siyan. Pediatric Drug-Induced Immune Thrombocytopenia Based on Real World Data and Quantitative Structure-Activity Relationship [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 16-22.
[15]	JIA Juanjuan, SUN Jiabei, ZHANG Wenzai, SUN Deyang, SHI Yaqin, HUANG Haiwei. Biological Distribution of ^99mTc-DMSA Injection [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 47-52.